NCT00570843View on ClinicalTrials.gov

Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Comfort, Vision and Wear Time
Interventions
DRUG

New PEG based artificial tear

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

DRUG

Optive

1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

Trial Locations (1)

10021

The New York Presbyterian Hospital-Weill Cornell Medical College, New York

Sponsors

Lead Sponsor

Bp Consulting, Inc
All Listed Sponsors
lead

Bp Consulting, Inc

NETWORK

NCT00570843 - Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses | Biotech Hunter | Biotech Hunter